If you’ve ever had a serious or chronic illness you know the routine: a line-up of all the little pills beside the breakfast plate, or maybe one of those little-old-lady boxes with a cubicle for each day, or perhaps a high-end color-coded wheel of medical fortune.
Now, it turns out, for a mere $100+ or so you can have a machine that does it all for you. Counts out the pills, spits them into a little cup, rings a bell when it’s time to pop another, calls your family if you skip something. When technology can address an issue, count on someone to perfect it. Even if its complexity boggles the mind.
Actually, for aging adults who must rely on a whole bunch of pills, these devices turn out to be a real boon. We learned this in a news release just out from the Center for Technology and Aging, through its Medication Optimization Position Paper, which is far more useful than its tongue-twisting name would have you believe.
The Center for Technology and Aging, a non-profit organization that was founded in 2009 with a grant from The SCAN Foundation (www.thescanfoundation.org,) is affiliated with the Public Health Institute (www.phi.org). It aims to find and advance technologies that help older adults stay independent and lead healthier lives — including technology for monitoring patients, for helping with tasks, social networking… and keeping track of pills.
It turns out, there are pill-counting wonders of every sort and price range. So if you can’t remember which vitamin comes before which super-drug, or you think Mom and Dad won’t remember, there’s a tech-app for that.
A commentary about cancer screenings and surrounding questions posted yesterday brought a thoughtful reader response: “Science, including public health,” wrote davidlosangeles, “is an evolving process.” Unquestionably so.
What we the consuming public need to understand is not the science as much as the personal responsibility. Today’s New York Times features another story on the front page of the Business section (some of us still follow old-fashioned newsprint) by Duff Wilson about “Research Uproar at a Cancer Clinic”, namely the highly regarded Carle Foundation Cancer Center in Urbana, IL. It’s another instance of respected professionals questioning each others’ respectability — or protocols, or carefulness, to use gentler terms than are actually being used. One of the issues raised is that of informed consent, and here is where we the consuming public come in. Whether we are cancer patients, CFIDS sufferers or mostly healthy people susceptible to the usual ails, it is incumbent upon the individual to know what he or she is agreeing to, and to know as much as possible about the projected outcome. We’re all in a giant clinical trial here on the planet. Nobody really knows about the outcome, but participation in mini-trials along the way can be valuable and is certainly laudable. Just know what you’re doing.
I am a continuing participant in the Women’s Health Initiative study now well into its second decade, though the primary issues are over and done with. I didn’t try any new hormone replacement therapies or drastic lifestyle changes, mainly because I’m pretty wimpish, but I read every word of the small print in the reams of documents that came along and tried hard to appreciate what the pitfalls and premises were. It was a valuable study, and hopefully will continue to turn up usable data.
Other studies are underway, and more will undoubtedly begin, regarding the current hoopla over XRMV, and H1N1. And heaven only knows how many other viruses, techonological advances, genetic possibilities and scientific wonders are out there to create great harm or great benefit.
Since the benefits are to the buyers, it’s appropriate that the buyer beware.